Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 60Recruiting 13Active not recruiting 10Unknown 9Not yet recruiting 8Withdrawn 3Terminated 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Motor Activity 2Polycystic Ovary Syndrome 1Neoplasms 1Insulin Resistance 1Body Weight 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Resistance Training × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

NCT02192216 2018-03-01

The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy

Department of Public Health, Denmark

Phase NA Terminated
16 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡